Proof of concept of FOLDAVALVE, a novel 14 Fr totally repositionable and retrievable transcatheter aortic valve.

AIMS Transcatheter aortic valve implantation (TAVI) is an emerging field with technological challenges. One major challenge is to minimise delivery catheter size to reduce vascular trauma, while maintaining features such as repositionability and retrievability. This study was designed as proof of concept of FOLDAVALVE, using a short-term ovine model. METHODS AND RESULTS FOLDAVALVE is a fully repositionable and retrievable transcatheter aortic valve with a 14 Fr delivery system whose leaflets are excluded from the stent during crimping. A short-term ovine model (n=3) was used for transfemoral implantations at the Institut Mutualiste Montsouris in Paris. There was a smooth transition of the valve over the aortic arch followed by seamless delivery into the native ovine aortic position. Implantation was followed by repositioning, resheathing and retrieval, then implantation of a fresh prosthesis in the same animal. Transoesophageal echocardiography and fluoroscopy were used to monitor the delivery and implantation processes and to demonstrate valve functionality. Animal sacrifice and direct visualisation after explant confirmed excellent final position. CONCLUSIONS FOLDAVALVE was successfully implanted in the aortic position of an ovine model. FOLDAVALVE is a promising technology which has been shown to be feasible in this preclinical TAVI study.

[1]  P. Serruys,et al.  The SURTAVI model: proposal for a pragmatic risk stratification for patients with severe aortic stenosis. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[2]  S. Pocock,et al.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.

[3]  O. Alfieri,et al.  Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: a propensity score-matched case-control study. , 2012, American heart journal.

[4]  Patrick Bruneval,et al.  Evidence of leaflet injury during percutaneous aortic valve deployment. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[5]  Arash Kheradvar,et al.  The effects of transcatheter valve crimping on pericardial leaflets. , 2014, The Annals of thoracic surgery.

[6]  Thomas Walther,et al.  Crimping may affect the durability of transcatheter valves: an experimental analysis. , 2011, The Annals of thoracic surgery.

[7]  David B. Jones,et al.  New frontiers in aortic therapy: focus on current trials and devices in transcatheter aortic valve replacement. , 2015, Journal of cardiothoracic and vascular anesthesia.

[8]  M. Morice,et al.  Transfemoral aortic valve implantation new criteria to predict vascular complications. , 2011, JACC. Cardiovascular interventions.

[9]  Arash Kheradvar,et al.  The Effects of Positioning of Transcatheter Aortic Valves on Fluid Dynamics of the Aortic Root , 2014, ASAIO journal.

[10]  Stuart J Pocock,et al.  Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.

[11]  Erich Wintermantel,et al.  Impairment of pericardial leaflet structure from balloon-expanded valved stents. , 2012, The Journal of thoracic and cardiovascular surgery.

[12]  M. Leon,et al.  Challenges and future opportunities for transcatheter aortic valve therapy. , 2014, Progress in cardiovascular diseases.

[13]  Maurice Buchbinder,et al.  Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.